Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yukmijihwang-tang for Cough-Variant Asthma (Phase 2 RCT)
KCT0006994Phase 2Not yet recruiting
- Sponsor
- Korea Institute of Oriental Medicine
- Start
- Jun 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cough variant asthma (CVA) comparing Yukmijihwang-tang with Placebo (2 arms). Planned start Jun 2022; status: not yet recruiting.
02
Drugs
yukmijihwang-tang
03
Conditions
cough variant asthma (CVA)
Beyond the preview
Go deeper on KCT0006994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006994.